Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selective pharmacophore design for alpha1-adrenoceptor subtypes.

Iain J A MacDougall1, Renate Griffith

  • 1School of Environmental and Life Sciences, The University of Newcastle, Australia.

Journal of Molecular Graphics & Modelling
|January 13, 2006
PubMed
Summary

This study developed pharmacophores for alpha1-adrenoceptor antagonists, aiding drug design for vasoconstriction. The models show good predictivity for subtype-selective compounds, minimizing side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Q1291H-CFTR molecular dynamics simulations and <i>ex vivo</i> theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patient.

Frontiers in molecular biosciences·2023
Same author

Development of Potential Inhibitors for Human T-lymphotropic Virus Type I Integrase Enzyme: A Molecular Modeling Approach.

Current computer-aided drug design·2023
Same author

Computational Evaluation of N-Based Transannular Interactions in Some Model Fused Medium-Sized Heterocyclic Systems and Implications for Drug Design.

Molecules (Basel, Switzerland)·2023
Same author

S945L-CFTR molecular dynamics, functional characterization and tezacaftor/ivacaftor efficacy <i>in vivo</i> and <i>in vitro</i> in matched pediatric patient-derived cell models.

Frontiers in pediatrics·2022
Same author

Molecular Dynamics and Theratyping in Airway and Gut Organoids Reveal R352Q-CFTR Conductance Defect.

American journal of respiratory cell and molecular biology·2022
Same author

Molecular dynamics and functional characterization of I37R-CFTR lasso mutation provide insights into channel gating activity.

iScience·2022

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Computational Chemistry

Background:

  • Alpha1-adrenoceptors are key G-protein coupled receptors mediating vasoconstriction in vascular tissues.
  • Subtype selectivity (alpha1a, 1b, 1d) is crucial for designing effective drugs with minimal side effects.

Purpose of the Study:

  • To develop ligand-based pharmacophores for alpha1a, alpha1b, and alpha1d adrenoceptor subtypes.
  • To aid in the rational design of selective alpha1-adrenoceptor antagonists.

Main Methods:

  • Utilized Catalyst software to generate pharmacophores from literature data for three distinct training sets.
  • Developed four-feature pharmacophores for alpha1a and alpha1b subtypes, and a five-feature pharmacophore for the alpha1d subtype.
  • Validated pharmacophore models using independent test sets and preliminary docking studies with AutoDock.

Related Experiment Videos

Main Results:

  • The alpha1a pharmacophore accurately predicted both class I and II compounds, demonstrating broad applicability.
  • The alpha1b pharmacophore showed high predictivity for prazosin analogues, its primary constituent.
  • The alpha1d pharmacophore, despite being based on a limited structural class, exhibited good predictivity for diverse compounds.

Conclusions:

  • Developed subtype-selective pharmacophores for alpha1-adrenoceptors, valuable tools for drug discovery.
  • Pharmacophore models provide a basis for designing novel antagonists with improved selectivity and reduced side effects.
  • Docking studies corroborated the pharmacophore findings, supporting their utility in drug design.